Foresite Capital Management IV, LLC LYEL Holdings History
Foresite Capital Management IV, LLC's Lyell Immunopharma Inc Holding Summary
As of 2025-03-31, Foresite Capital Management IV, LLC held 800,399.95 shares of Lyell Immunopharma Inc(LYEL), totaling $8.61 Mil. This investment constitutes 7.75% of their stock portfolio, and Foresite Capital Management IV, LLC now holds 5.42% of the outstanding Lyell Immunopharma Inc(LYEL) stock.
The initial trade took place in 2021Q2. And since then Foresite Capital Management IV, LLC has made 2 purchases of LYEL, at an average price of $212.30, for a total of 1.05 Mil shares. In addition, there have been 4 sales at an average price of $105.09 for 247,859.05 shares. Based on historical transaction data and LYEL's current price of $10.41, Foresite Capital Management IV, LLC's estimated gain on his LYEL holdings is $-188.17 Mil, reflecting a -84.55% gain to date.
Foresite Capital Management IV, LLC LYEL ($10.41) Holding Chart
Foresite Capital Management IV, LLC LYEL ($10.41) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
